通过抑制死亡素-p53封存来恢复p53功能:癌症治疗中的新兴目标
相关实验视频
Updated: Jul 12, 2025

10:55
Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
2.2K
Akshatha Handattu Shankaranarayana1, Bhagyalalitha Meduri1, Gurubasavaraj Veeranna Pujar1
1Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Sri Shivarathreeshwara Nagara, Mysuru, 570015, India.
Future medicinal chemistry
|October 25, 2023
概括
癌细胞会使p53蛋白失活,通常是通过死亡蛋白. 抑制mortalin-p53结合可能通过恢复p53功能来改善癌症患者的生存率.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 野生类型的p53无活化是癌症的标志.
- 通过TP53基因突变或过度表达p53结合伙伴而发生p53失活.
- 线粒体热冲击蛋白Mortalin在癌细胞中结合并隔离p53.
研究的目的:
- 审查mortalin在癌症中的p53隔离中的作用.
- 探索高死亡素表达的临床影响.
- 讨论开发死亡素-p53封存抑制剂的策略.
主要方法:
- 关于p53,mortalin和癌症的研究的文献综述.
- 对临床数据的分析,将死亡素表达与患者存活率相关联.
- 药物发现方法的探索针对蛋白质-蛋白质相互作用.
主要成果:
- 莫塔林过度表达导致恶性细胞中的p53封存.
- 高死亡素表达与癌症患者的整体存活率降低有关.
- 针对mortalin-p53相互作用提供了一个治疗机会.
结论:
- 莫尔塔林-p53封存是癌症进展中的关键机制.
- 死亡素-p53封存的抑制剂具有改善癌症治疗的潜力.
- 需要进一步的研究和药物开发来利用这种治疗策略.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
DNA Damage can Stall the Cell Cycle
9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
Loss of Tumor Suppressor Gene Functions
4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K

